Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-034839

G1 Therapeutics, Inc. · GTHX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Clay Thorp
10% Owner
John Crumpler
10% Owner
Period of report
May 30, 2018
Accepted (ET)
Jun 1, 2018 · 6:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001560241

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3May 30, 2018S758,290$48.00D3,279,421ISee Footnotes
Common StockF1,F4,F5May 30, 2018S41,710$48.00D3,237,711ISee Footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses